ArticleACS medicinal chemistry letters2026

Development of 2‑Methyl-5-phenylpyrrolidine-Based ST2 Inhibitors for Neuroinflammatory Conditions.

Xinrui Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.